Overview

Tolvaptan for Hyponatremia in Cirrhotic Patients With Ascites

Status:
Unknown status
Trial end date:
2014-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to investigate the efficacy and safety for the management of hyponatremia and ascites in patients with liver cirrhosis.
Phase:
Phase 4
Details
Lead Sponsor:
Konkuk University Medical Center
Collaborators:
Chung-Ang University Hosptial, Chung-Ang University College of Medicine
Chungnam National University
Hallym University Medical Center
Hanyang University
Incheon St.Mary's Hospital
Inha University Hospital
Inje University
Korea University Anam Hospital
Kyungpook National University
Kyungpook National University Hospital
Samsung Medical Center
Seoul St. Mary's Hospital
Severance Hospital
Soonchunhyang University Hospital
Treatments:
Tolvaptan